Steri-Med Pharma
Company intelligence

Steri-Med Pharma Company Intelligence, Employees & Contact Signals

Contact coverage
Email-led
Visible profile or company source data is strongest for email outreach. 3 visible profiles include direct contact evidence.
People graph depth
4 signals
4 mapped workforce signals against a 21 employee size estimate.
Account research
6 steps
Account research checklist combines person-level contact coverage, buying-committee coverage, ICP fit, related-company graph, domain trust, and people graph depth; raw contact values are hidden.
Social audience
1.26K
Audience size from company social follower data.
Evidence quality 100/100 Priority intelligence record

AeroLeads company intelligence

Steri-Med Pharma workforce and contactability signals

Evidence from AeroLeads company records, matched professional profiles, and related company graph.

High confidence
Intelligence completeness
Strong intelligence record
7 of 11 major intelligence groups are available for this company.
Profile graph
Moderate profile graph
4 mapped workforce signals against a 21 employee size estimate.
Top seniority band
Individual contributor
2 of 4 classified profile signals.
Visible contact sample
3
Displayed people with email or phone data.
Social followers
1.26K
Audience size from company social data.

Profile graph researchability

Visible people graph includes 4 visible people: 4 named, 4 titled, 3 located, and 3 contactable.

Profile research sample
Profile coverage evidence tier: Moderate profile coverage evidence. Profile coverage evidence combines 4 mapped workforce signals, 21 employee size estimate, and 19.0% profile graph coverage.
Corroborated profile graph evidence: Researchability is based on 4 visible people with 4 populated evidence dimensions: named, titled, located, and contactable signals.
Profile association confidence: Profile association sample. Association confidence combines 4 titled profiles and 3 contactable profiles.
People
4
Named
4
Titled
4
Located
3
Contactable
3

Data methodology

AeroLeads renders only source-backed fields for this company page.

5 source groups
Company record Matched profile graph Email-pattern aggregate Related company graph Company signal fields
Blank source fields are omitted
Related companies are ordered deterministically
Structured data uses aggregate counts only

Intelligence completeness

7 of 11 major intelligence groups are available for this company.

7 / 11 groups
Strong intelligence record 63.6%
Workforce composition Contactability Email intelligence Decision makers Buying committee Domain confidence Market and peer context

Evidence quality

This page clears the 60+ AeroLeads company-intelligence evidence threshold.

100 / 100
Priority intelligence record Threshold 60+
Employee email coverage Role title reachability Decision-maker coverage Related company graph Peer graph strength Peer position benchmark
Contactability
7 signals
Employee email coverage, Contact channel mix, Contact data safety guardrail
Workforce graph
15 signals
Role title reachability, Profile graph researchability, Workforce location footprint
Decision-maker intelligence
6 signals
Decision-maker coverage, Decision-maker reachability, Decision-maker channel mix
Market and peer context
14 signals
Related company graph, Peer graph strength, Peer position benchmark
Company momentum
3 signals
Company signal breadth, Company momentum score, Company ownership signal
Source trust
9 signals
Domain confidence, Intelligence completeness, Company description
48 additional source-backed evidence signals are counted in this page quality score.

Prospecting readiness

Steri-Med Pharma shows actionable prospecting fit based on person-level contact coverage, decision-maker coverage, people graph depth, and peer context.

60 / 100
Actionable prospecting fit Corroborated prospecting evidence

Prospecting evidence combines person-level contact coverage, decision-maker coverage, people graph depth, and peer context; raw contact values are hidden.

ICP fit
Qualified ICP fit

ICP fit combines company size, market specificity, contactability, and buying committee; raw contact values are hidden.

70 / 100
Company size
21 employees
Employee estimate is in a common outbound prospecting range.
Market specificity
Tagged market profile
2 category and specialty signals in the company record.
Reachability
Mapped contact-channel evidence
Visible profile or company source data is strongest for email outreach.
Buying committee
Mapped buying committee
Mapped decision-maker signals span 1 business function.
Account research checklist
Multi-step account research checklist

Account research checklist combines person-level contact coverage, buying-committee coverage, ICP fit, related-company graph, domain trust, and people graph depth; raw contact values are hidden.

6 steps
Confirm contact coverage
Mapped contact-channel evidence
Visible profile or company source data is strongest for email outreach.
Map reachable buying committee
Mapped buying committee
Buying-committee evidence combines 1 mapped buying-committee function, 1 contactable function, and Executive / corporate function coverage.
Validate ICP fit
Qualified ICP fit
ICP fit combines company size, market specificity, contactability, and buying committee; raw contact values are hidden.
Compare related peers
Limited peer comparison
Compares this company with related-company evidence across employee scale and peer graph evidence.
Check domain trust
Mixed domain alignment
Domain evidence combines website domain and social profile; raw email addresses are hidden.
Review people graph depth
Moderate profile graph
4 mapped workforce signals against a 21 employee size estimate.
Contact coverage
Mapped contact-channel evidence
Visible profile or company source data is strongest for email outreach.
Decision-maker coverage
Mapped buying committee
Mapped decision-maker signals span 1 business function.
People graph depth
Moderate profile graph
4 mapped workforce signals against a 21 employee size estimate.
Peer context
Multi-signal peer benchmark evidence
Peer benchmark combines 10 related companies with peer graph strength, size benchmark, and size position. Underlying peer graph includes 4 evidence types: industry context, employee benchmarks, website records, social profiles.

Domain trust signals

Domain confidence for sterimedpharma.com is based on website domain and social profile.

35 / 100
Mixed domain alignment Limited domain evidence

Domain evidence combines website domain and social profile; raw email addresses are hidden.

Website domain
sterimedpharma.com
The official website domain is available from the company source record.
Social profile
LinkedIn organization page
A LinkedIn organization page is present for this company record.
Employee email mismatch: Visible employee email signals do not match the official domain.

AeroLeads coverage snapshot

Profile sample
4
Visible people attached to this company page.
Profile graph depth
Moderate profile graph
4 mapped workforce signals against a 21 employee size estimate.
Contactable sample
3
Visible people with email or phone data.
Contact channel mix
Email-led contact coverage
Visible profile or company source data is strongest for email outreach.
Contact evidence confidence
Mapped contact-channel evidence
Visible profile or company source data is strongest for email outreach.
Email domain confidence
Non-official email coverage
Visible email signals use non-official domains only.
Domain confidence
Mixed domain alignment
Domain confidence for sterimedpharma.com is based on website domain and social profile.
Contact data safety
Limited privacy-safe contact intelligence
AeroLeads exposes contact counts, channel mix, freshness, and domain-alignment evidence while hiding raw email addresses and masking phone numbers in public output.
Company signal breadth
Two-signal company record
Company-level signals include social audience and ownership.
Company momentum score
Limited company momentum score
Momentum score blends contactability and peer position from AeroLeads company and profile evidence.
Company ownership signal
Private company record
Company source record includes source type Privately Held.
Audience density
Moderate audience density
1.26K followers against 21 employee estimate, about 60.20 followers per estimated employee.
Specialty signals
1
Specialty tags in the company record.
Market specificity
Tagged market profile
2 category and specialty signals in the company record.
Peer industry clusters
2
Industries represented by related company records.
Related companies
10
Company graph links available for comparison.
Industry benchmark
Evidence-backed industry benchmark
Industry benchmark uses 10 related companies, 9 same-industry peers, 3 benchmark dimensions, and 4 peer evidence types from the AeroLeads related-company graph.
Peer benchmark confidence
Multi-signal peer benchmark evidence
Peer benchmark combines 10 related companies with peer graph strength, size benchmark, and size position. Underlying peer graph includes 4 evidence types: industry context, employee benchmarks, website records, social profiles.
Peer position benchmark
Employee-scale peer position benchmark
Peer-position benchmark shows employee scale above 20% of 10 comparable related peers.
Peer comparison matrix
Limited peer comparison
Compares this company with related-company evidence across employee scale and peer graph evidence.
Workforce locations
3
Locations represented in visible profile signals.
Workforce distribution
Multi-location workforce
Visible profile location signals span 3 locations, led by Capitale-nationale, Quebec, Canada.
Workforce location footprint
Multi-city workforce footprint
Visible profile locations span 3 cities across 1 country, led by Capitale-nationale.
Workforce distribution model
Workforce hub outside company location
The largest visible workforce hub is Capitale-nationale, Quebec, Canada, while the company location is Upton, Quebec, Ca.
Workforce geography evidence confidence
Corroborated workforce geography evidence
Workforce geography spans 3 locations across 3 visible profile signals, with reachable evidence across 3 locations. Top workforce hub differs from company location.
Contactable workforce locations
3
Workforce locations represented by visible contact samples.
Top contactable workforce location
Capitale-nationale, Quebec, Canada
Visible contact samples span 3 workforce locations, led by Capitale-nationale, Quebec, Canada.
Workforce seniority tiers
3
Seniority bands derived from visible profile titles and levels.
Seniority evidence confidence
Corroborated seniority evidence
Seniority graph spans 4 classified profile signals across 3 tiers, with reachable evidence for 3. Balanced management-to-IC sample.
Classified seniority profiles
4
Visible profiles with usable seniority signals.
Management-to-IC proxy
Balanced management-to-IC sample
2 managerial seniority signals and 2 contributor signals appear in the visible seniority-classified sample.
Role title diversity
Diverse role title sample
4 distinct role titles across 4 visible titled profiles.
Visible role titles
4
Distinct role titles found in visible profile signals.
Contactable role titles
3
Distinct role titles with visible contact samples.
Contactable role coverage
Diverse contactable role coverage
3 reachable role titles across 3 contactable titled profiles.
Decision-maker signals
2
Visible profiles matching seniority or leadership title patterns.
Decision-maker reachability
Partial decision-maker reachability
Some mapped decision-maker signals include visible contact data.
Buying committee evidence confidence
Mapped buying committee
Mapped decision-maker signals span 1 business function.
Buyer persona availability
Single-persona buyer availability
Mapped decision-maker evidence covers Executive buyer; 1 of 1 buyer persona include visible contact data.
Decision-maker contactability rate
50
Percent of mapped decision-maker signals with visible contact data.
Prospecting fit
Actionable prospecting fit
Steri-Med Pharma shows actionable prospecting fit based on person-level contact coverage, decision-maker coverage, people graph depth, and peer context.
ICP fit
Qualified ICP fit
Steri-Med Pharma matches the qualified ICP fit band for common outbound filters based on company size, market specificity, contactability, and buying committee.
Account research checklist
Multi-step account research checklist
Account research checklist combines person-level contact coverage, buying-committee coverage, ICP fit, related-company graph, domain trust, and people graph depth; raw contact values are hidden.
Intelligence signal groups
14
AeroLeads signal groups available for this company.

Market focus signals

Primary industry
Pharmaceutical Manufacturing
Market specificity
Tagged market profile
2 category and specialty signals in the company record.
Market evidence tier
Corroborated market evidence
Market evidence combines 4 classification signals from categories, specialties, related peer industries, and description keywords. 6 description-backed keyword signals are included.
Industry benchmark
Evidence-backed industry benchmark
Industry benchmark uses 10 related companies, 9 same-industry peers, 3 benchmark dimensions, and 4 peer evidence types from the AeroLeads related-company graph.
Top peer industry
Pharmaceutical Manufacturing
90% of 10 related peer industry signals.
Peer benchmark evidence
Multi-signal peer benchmark evidence
Peer benchmark combines 10 related companies with peer graph strength, size benchmark, and size position. Underlying peer graph includes 4 evidence types: industry context, employee benchmarks, website records, social profiles.
Size position
Smaller than most related peers
8 of 10 related employee-estimated peers are higher.
Peer graph strength
Benchmark-ready peer graph
Related peer graph has industry context, employee benchmarks, website records, and social profiles across 10 related companies.
Benchmark dimensions: peer graph strength, size benchmark, and size position.
Categories
Pharmaceutical Manufacturing
Specialties
Pharmaceutique and Fabrication de médicaments
Product-market keyword evidence
Description-backed market keywords
Keyword evidence comes from 3 source field groups: Category, Specialty, Description.
Product-market keyword evidence tier: High-confidence product-market keyword evidence. Product-market keyword evidence combines 8 unique market keywords, 3 source field groups, and 6 description-backed keywords (1 category, 1 specialty, and 6 description).
Pharmaceutical Manufacturing · Category Pharmaceutique and Fabrication de médicaments · Specialty les laboratoires sterigen · Description entreprise laboratoires sterigen · Description liorations qui · Description poursuivent nous sommes · Description senter notre nouvelle · Description nouveau logo · Description
Related peer industries
Peer-industry evidence tier: High-confidence peer-industry evidence. Peer-industry evidence combines 10 related companies, 2 peer-industry clusters, and top peer industry Pharmaceutical Manufacturing at 90.0%.
Pharmaceutical Manufacturing 9 peers
90.0% of related peer industries
Biotechnology 1 peer
10.0% of related peer industries

Company signals

Company signal breadth
Two-signal company record
Company-level signals include social audience and ownership.
Corroborated company record evidence: Company record evidence combines 2 source-backed company signal types: social audience and ownership.
Social audience
1.26K
Followers in the company source record.
Social audience evidence tier: Limited social-audience evidence. Social audience evidence uses 1.26K followers from source field social_followers.
Audience density
Moderate audience density
1.26K followers against 21 employee estimate, about 60.20 followers per estimated employee.
Audience-density evidence tier: Corroborated audience-density evidence. Audience-density evidence combines 1.26K social followers, 21 employee estimate, and 60.20 followers per estimated employee.
Company ownership
Private company record
Company source record includes source type Privately Held.
Company ownership evidence tier: Structured ownership evidence. Ownership evidence combines source type Privately Held from structured company source fields.

Workforce seniority mix

Aggregated from 4 classified profile signals.

Largest seniority band
Individual contributor
2 of 4 classified profile signals, 2 with visible contact data.
Corroborated seniority evidence: Seniority graph spans 4 classified profile signals across 3 tiers, with reachable evidence for 3. Balanced management-to-IC sample.
Management-to-IC proxy
Balanced management-to-IC sample
50.0%
managerial seniority signals
50.0%
contributor seniority signals
2 managerial seniority signals and 2 contributor signals appear in the visible seniority-classified sample.
Management-shape evidence tier: Balanced management-shape evidence. Management-shape evidence combines 4 seniority-classified signals, 2 managerial signals, 50.0% managerial share, and 2 contributor signals.
Individual contributor 2 profiles
50.0% of classified seniority signals, 2 with visible contact data
Executive 1 profile
25.0% of classified seniority signals, 1 with visible contact data
Manager 1 profile
25.0% of classified seniority signals

Workforce geography

Aggregated from 3 visible profile location signals.

Workforce geography evidence
Corroborated workforce geography evidence
Workforce geography spans 3 locations across 3 visible profile signals, with reachable evidence across 3 locations. Top workforce hub differs from company location.
Distribution signal
Multi-location workforce
Visible profile location signals span 3 locations, led by Capitale-nationale, Quebec, Canada.
Workforce distribution model
Workforce hub outside company location
The largest visible workforce hub is Capitale-nationale, Quebec, Canada, while the company location is Upton, Quebec, Ca.
Corroborated workforce model evidence: Workforce model evidence combines 3 located profile signals, 3 workforce locations, 3 cities, 1 country, top hub Capitale-nationale, Quebec, Canada at 33%, company-location alignment, and 3 reachable locations.
Locations
3
Countries
1
Top hub share
33%
Workforce location footprint
Multi-city workforce footprint
Visible profile locations span 3 cities across 1 country, led by Capitale-nationale.
Cities
3
Countries
1
Company-location alignment
Top workforce hub differs from company location
The largest visible workforce location is Capitale-nationale, Quebec, Canada, while the company location is Upton, Quebec, Ca.
Top workforce hub share: 33.3%
Company-location evidence tier: Workforce-location divergence evidence. Company-location alignment evidence combines company location Upton, Quebec, Ca, top workforce hub Capitale-nationale, Quebec, Canada, 33.3% top workforce hub share, and location difference.
Contactable location spread
Multi-location contact coverage
Visible contact samples span 3 workforce locations, led by Capitale-nationale, Quebec, Canada.
Contactable location evidence tier: High-confidence contactable location evidence. Contactable location evidence combines 3 contactable profile location signals, 3 workforce locations, top contactable hub Capitale-nationale, Quebec, Canada at 33.3%, and company-location alignment.
Contactable workforce hub differs from company location: The largest contactable workforce location is Capitale-nationale, Quebec, Canada, while the company location is Upton, Quebec, Ca. Top contactable hub share: 33.3%.
Capitale-nationale, Quebec, Canada 1 contact
33.3% of contactable location signals
Saint-simon, Quebec, Canada 1 contact
33.3% of contactable location signals
Longueuil, Quebec, Canada 1 contact
33.3% of contactable location signals
Capitale-nationale, Quebec, Canada 1 profile
33.3% of visible location signals
Saint-simon, Quebec, Canada 1 profile
33.3% of visible location signals
Longueuil, Quebec, Canada 1 profile
33.3% of visible location signals

Decision-maker coverage

2 seniority signals, 1 with visible contact data.

Decision-maker evidence tier
Mapped decision-maker evidence
Decision-maker evidence covers 2 seniority signals, 1 reachable. Buying committee spans 1 function.
Account planning snapshot
Focused account planning snapshot
Snapshot combines department reachability, decision-maker coverage, and buying-committee function aggregates.
2 account-planning evidence cards available.
Account planning evidence tier: Corroborated account planning evidence. Account planning evidence combines 2 aggregate account-planning cards, 1 reachable buying-committee function, and Executive seniority reachability; raw contacts are hidden.
Reachable buying committee
1 of 1 functions
Reachable functions include Executive / corporate.
Most reachable seniority
Executive
1 of 1 signals in this seniority band include visible contact data.
Partial decision-maker reachability 50.0%
Some mapped decision-maker signals include visible contact data.
Decision-maker reachability evidence tier: Partial decision-maker reachability evidence. Decision-maker reachability evidence combines 1 contactable decision-maker signal, 2 mapped decision-maker signals, and 50.0% contactability.
Email-led decision-maker coverage: Mapped decision-maker contact data is strongest for email, with 1 email signals.
Buying committee function coverage
Single-function buying-committee coverage
1 of 1 mapped functions include visible decision-maker contact data.
Mapped buying committee: Mapped decision-maker signals span 1 business function.
Buying committee evidence tier: Mapped buying-committee evidence. Buying-committee evidence combines 1 mapped buying-committee function, 1 contactable function, and Executive / corporate function coverage.
Buyer persona availability: Single-persona buyer availability. Mapped decision-maker evidence covers Executive buyer; 1 of 1 buyer persona include visible contact data. Reachable buyer persona evidence: Buyer persona evidence combines 1 mapped buyer persona, 1 contactable persona, and Executive buyer coverage.
Executive / corporate: 1 contactable
Most reachable seniority
Executive
1 of 1 seniority signals include visible contact data.
Seniority reachability evidence tier: Mapped seniority reachability evidence. Seniority reachability evidence combines 1 contactable Executive signal, 1 Executive signal, 100.0% tier contactability, and email coverage.
Manager 1 profile
50.0% of mapped seniority signals
Executive 1 profile
50.0% of mapped seniority signals, 1 with visible contact data

Role and function mix

4 visible titled profiles across 4 distinct role titles.

Title mix
Diverse role title sample
4 distinct role titles across 4 visible titled profiles.
Role-title evidence tier: Diverse role-title evidence. Role-title diversity evidence combines 4 visible titled profiles, 4 distinct role titles, and top title Mmf Chez Steri-med Pharma at 25.0%.
Contactable role coverage
Diverse contactable role coverage
3 reachable role titles across 3 contactable titled profiles.
Contactable role evidence tier: Diverse contactable role evidence. Contactable role evidence combines 3 contactable titled profiles, 3 reachable role titles, and top reachable role Mmf Chez Steri-med Pharma at 33.3%.
Role title reachability
Broad role-title reachability
3 of 4 distinct visible role titles include email or phone signals.
Role-title reachability evidence tier: Corroborated role-title reachability evidence. Role-title reachability evidence combines 4 visible role titles, 3 reachable titles, and 75.0% title reachability.
Mmf Chez Steri-med Pharma 1 profile
25.0% of visible titled profiles
Production Manager Glaxosmithkline 1 profile
25.0% of visible titled profiles
Président & CEO - Groupe Lsl Pharma Inc. 1 profile
25.0% of visible titled profiles
Technicienne Contrôle Qualité Chez 1 profile
25.0% of visible titled profiles

Contactability signals

Contactability score 75.0%
3 of 4 visible profiles include email or phone signals.
Contact channel mix
Email-led contact coverage
Visible profile or company source data is strongest for email outreach.
Contact evidence tier
Mapped contact-channel evidence
Visible profile or company source data is strongest for email outreach.
Contact data safety
Limited privacy-safe contact intelligence
AeroLeads exposes contact counts, channel mix, freshness, and domain-alignment evidence while hiding raw email addresses and masking phone numbers in public output.
Aggregate signals
3
Channel coverage
Email aggregate coverage
Evidence groups
1
Limited contact-safety evidence: Contact-safety evidence combines visible profile contact sample; public schema uses aggregate variables only.
Aggregate-only contact schema: Dataset variables use counts, rates, channel labels, freshness bands, and domain-alignment metrics instead of raw contact values.
Visible people
4
With contact data
3
Email coverage
3
75.0% of visible profiles

Email domain intelligence

0 of 5 visible email signals match sterimedpharma.com.

Non-official email coverage: Visible email signals use non-official domains only.
Email identity evidence tier: Non-official email identity evidence. Email identity evidence combines 5 visible email signals, 3 other-domain signals, and 2 personal-domain signals.
0.0% domain match 0 people with official-domain email 5 non-official email signals

Explore related pages

Related company intelligence:

Les Laboratoires Sterigen inc." devient Steri-Med Pharma inc. L’acquisition de l’entreprise Laboratoires Sterigen par Laboratoire LSL en juillet 2019 a amené un vent de changements et d’améliorations qui se poursuivent. Nous sommes heureux de vous présenter notre nouvelle image corporative affichant un nouveau logo. Steri-Med Pharma œuvre toujours dans la fabrication de produits stériles, dont les onguents Sterisporin et Erythromycin, et est à développer de nouveaux produits sous forme de gouttes, onguents et injectables. Si vous êtes à la recherche d’un fabricant ou un partenaire pour le développement de produits stériles, n’hésitez pas à communiquer avec nous à l’adresse info@sterimedpharma.com, il nous fera plaisir de vous assister dans vos projets. Suivez-nous sur linkedin et soyez informé des derniers développements !

Company source details

Employees
21
Address
Upton, Quebec, Ca
Industry
Pharmaceutical Manufacturing
NAICS
Pharmaceutical and Medicine Manufacturing
Medicinal and Botanical Manufacturing
Pharmaceutical Preparation Manufacturing
In-Vitro Diagnostic Substance Manufacturing
Biological Product (except Diagnostic) Manufacturing
Website
www.sterimedpharma.com
Keywords
Pharmaceutique and Fabrication de médicaments.
HQ
Upton, Québec
Related companies
Pharmascience, JAMP Pharma Group, Jubilant Radiopharma, Jefo, Jubilant Pharma Limited, Mantra Pharma, Omega Laboratories Ltd., Sterinova, Groupe LSL Pharma, Laboratoire LSL.
Explore visible people signals for Steri-Med Pharma by role, title, or keyword.

3 of 4 visible profiles include email or phone signals in AeroLeads.

Steri-Med Pharma Questions

News

LSL PHARMA GROUP ANNOUNCES $1.4 MILLION OF NEW ORDERS FROM INTERNATIONAL CLIENTS AND COMPLETION OF STERI-MED PHARMA'S PHASE 1 PRODUCTION SCALE UP - PR Newswire Canada

LSL PHARMA GROUP ANNOUNCES $1.4 MILLION OF NEW ORDERS FROM INTERNATIONAL CLIENTS AND COMPLETION OF STERI-MED PHARMA'S PHASE 1 PRODUCTION SCALE UP PR Newswire Canada

LSL PHARMA GROUP ENTERS INTO NON-BINDING AGREEMENT TO ACQUIRE A QUEBEC-BASED COMPETITOR - PR Newswire Canada

LSL PHARMA GROUP ENTERS INTO NON-BINDING AGREEMENT TO ACQUIRE A QUEBEC-BASED COMPETITOR PR Newswire Canada

Steri-Med Pharma people graph sample